KR7005690003
KR7005690003
Pharmicell
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 114.061.538.470 | 64.851.303.830 | 75.9% |
| Cost of Revenue | 63.384.963.030 | 43.521.158.230 | 45.6% |
| Gross Profit | 50.676.575.440 | 21.330.145.600 | 137.6% |
| 16.372.541.000 | 16.674.509.000 | 1.8% | |
| Operating Income | 34.304.034.440 | 4.655.636.600 | 636.8% |
| Pretax Income | 34.767.366.550 | 6.263.974.720 | 455.0% |
| Net Income Common Stockholders | 40.288.986.390 | 6.331.277.000 | 536.3% |
| -- | -- | -- | |
| -- | -- | -- |